Ong G - Search Results

1

Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens.

Reinsmoen NL, Patel J, Mirocha J, Lai CH, Naim M, Ong G, Wang Q, Zhang X, Liou F, Yu Z, Kobashigawa J. Reinsmoen NL, et al. Among authors: ong g. J Heart Lung Transplant. 2016 Feb;35(2):165-72. doi: 10.1016/j.healun.2015.10.013. Epub 2015 Oct 23. J Heart Lung Transplant. 2016. PMID: 26683810

2

Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.

Reinsmoen NL, Lai CH, Vo A, Cao K, Ong G, Naim M, Wang Q, Jordan SC. Reinsmoen NL, et al. Among authors: ong g. Transplantation. 2008 Sep 27;86(6):820-5. doi: 10.1097/TP.0b013e3181856f98. Transplantation. 2008. PMID: 18813107

3

Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.

Reinsmoen NL, Lai CH, Heidecke H, Haas M, Cao K, Ong G, Naim M, Wang Q, Mirocha J, Kahwaji J, Vo AA, Jordan SC, Dragun D. Reinsmoen NL, et al. Among authors: ong g. Transplantation. 2010 Dec 27;90(12):1473-7. doi: 10.1097/TP.0b013e3181fd97f1. Transplantation. 2010. PMID: 21030904

4

Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy.

Lai CH, Cao K, Ong G, Naim M, Wang Q, Mirocha J, Vo A, Jordan SC, Reinsmoen NL. Lai CH, et al. Among authors: ong g. Transplantation. 2011 Jul 15;92(1):48-53. doi: 10.1097/TP.0b013e31821eab8a. Transplantation. 2011. PMID: 21562450

5

Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome.

Reinsmoen NL, Lai CH, Mirocha J, Cao K, Ong G, Naim M, Wang Q, Haas M, Rafiei M, Czer L, Patel J, Kobashigawa J. Reinsmoen NL, et al. Among authors: ong g. Transplantation. 2014 Mar 15;97(5):595-601. doi: 10.1097/01.TP.0000436927.08026.a8. Transplantation. 2014. PMID: 24162250

6

An analysis of the xenogeneic response in an isolated liver perfusion circuit.

Lim SM, Cheang A, Chin LG, Heng KK, Li SQ, Lim NK, Ong GL, Poh LH, Seah ML. Lim SM, et al. Among authors: ong gl. Transplant Proc. 1992 Aug;24(4):1607-8. Transplant Proc. 1992. PMID: 1496673 No abstract available.

7

Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.

Kodali S, Hahn RT, Makkar R, Makar M, Davidson CJ, Puthumana JJ, Zahr F, Chadderdon S, Fam N, Ong G, Yadav P, Thourani V, Vannan MA, O'Neill WW, Wang DD, Tchétché D, Dumonteil N, Bonfils L, Lepage L, Smith R, Grayburn PA, Sharma RP, Haeffele C, Babaliaros V, Gleason PT, Elmariah S, Inglessis-Azuaje I, Passeri J, Herrmann HC, Silvestry FE, Lim S, Fowler D, Webb JG, Moss R, Modine T, Lafitte S, Latib A, Ho E, Goldberg Y, Shah P, Nyman C, Rodés-Cabau J, Bédard E, Brugger N, Sannino A, Mack MJ, Leon MB, Windecker S; the TRISCEND study investigators. Kodali S, et al. Among authors: ong g. Eur Heart J. 2023 Dec 7;44(46):4862-4873. doi: 10.1093/eurheartj/ehad667. Eur Heart J. 2023. PMID: 37930776

8

IFN-γ derived from activated human CD4⁺ T cells inhibits the replication of SARS-CoV-2 depending on cell-type and viral strain.

Shimizu J, Sasaki T, Ong GH, Koketsu R, Samune Y, Nakayama EE, Nagamoto T, Yamamoto Y, Miyazaki K, Shioda T. Shimizu J, et al. Among authors: ong gh. Sci Rep. 2024 Nov 4;14(1):26660. doi: 10.1038/s41598-024-77969-4. Sci Rep. 2024. PMID: 39496837 Free PMC article.

9

Use of a Septal Occluder to Treat Recurrent Tricuspid Regurgitation After TriClip.

Attumalil T, Alnasser S, Bisleri G, Ong G, Fam NP. Attumalil T, et al. Among authors: ong g. JACC Cardiovasc Interv. 2024 Oct 16:S1936-8798(24)01271-8. doi: 10.1016/j.jcin.2024.09.057. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 39480365 No abstract available.

10

The Selangor Consensus: strengthening clinical trials for local public health in the Western Pacific.

Experts Consultation on Implementing World Health Assembly Resolution WHA75.8 on Strengthening Clinical Trials in the Western Pacific Participants. Experts Consultation on Implementing World Health Assembly Resolution WHA75.8 on Strengthening Clinical Trials in the Western Pacific Participants. Lancet Reg Health West Pac. 2024 Jul 12;48:101136. doi: 10.1016/j.lanwpc.2024.101136. eCollection 2024 Jul. Lancet Reg Health West Pac. 2024. PMID: 39380745 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

688 results

Search Page

Filters